等待開盤 01-28 09:30:00 美东时间
-1.590
-4.38%
The most oversold stocks in the consumer staples sector presents an opportunity...
01-15 19:59
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
Keybanc analyst Scott Schoenhaus maintains ODDITY Tech (NASDAQ:ODD) with a Overweight and lowers the price target from $70 to $50.
01-08 22:18
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30
JP Morgan analyst Cory Carpenter maintains ODDITY Tech (NASDAQ:ODD) with a Overweight and lowers the price target from $67 to $59.
2025-12-13 03:09
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从6美元升至8美元;HC Wainwright & Co.:维持MediWound"买入"评级,目标价从31美元升至36美元
2025-11-24 11:23
Morgan Stanley analyst Dara Mohsenian maintains ODDITY Tech (NASDAQ:ODD) with a Equal-Weight and lowers the price target from $61 to $49.
2025-11-21 22:07
Oddity Tech shares are soaring in extended trading on Wednesday after the company reports better-than-expected results for the third quarter.
2025-11-20 05:57
ODDITY Tech将于2025年11月19日发布财报,预期每股收益0.31美元,营收1.457亿美元。上季度EPS为0.92美元,收入增长25.09%,净利率20.44%。公司刚宣布推出远程医疗服务METHODIQ。
2025-11-20 05:42
ODDITY Tech Ltd.将于2025年11月19日发布季度财报,预期每股收益0.31美元,并于前一日宣布推出远程医疗服务METHODIQ。
2025-11-20 05:21